CHEST Impact Factor 2022ChestnetThe ChestCHEST Journal indexingPulmonary articlesChest open accessCHEST journal 2022Chest Radiology JournalThe Chest
po文清單文章推薦指數： 80 %
關於「The Chest」標籤，搜尋引擎有相關的訊息討論：
延伸文章資訊
- 1PK/PD and Long Term Safety Study of Benralizumab in ...
To evaluate the pharmacokinetics (PK) of Benralizumab administered subcutaneously (SC) in childre...
- 2Study to Evaluate Efficacy and Safety of Benralizumab in ...
This is a study designed to evaluate efficacy and safety of Benralizumab in reducing the Oral Cor...
- 3Benralizumab, an anti-interleukin 5 receptor α monoclonal ...
Interpretation: Benralizumab at 20 mg and 100 mg doses seemed to reduce asthma exacerbations in a...
- 4Fasenra, INN-benralizumab - European Medicines Agency |
*Benralizumab is a humanised monoclonal antibody produced in Chinese hamster ovary (CHO) cells by...
- 5Fasenra | European Medicines Agency - European Union
The active substance in Fasenra, benralizumab, is a monoclonal antibody (a type of protein) desig...
